Ikarian Capital, LLC Synlogic, Inc. Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.91 - $14.63 $152,518 - $2.45 Million	-167,603 Reduced 35.33%	306,757 $292,000
Q2 2022 Aug 12, 2022	SELL	$0.89 - $2.47 $40,419 - $112,175	-45,415 Reduced 8.74%	474,360 $545,000
Q1 2022 May 13, 2022	BUY	$1.63 - $2.55 $58,609 - $91,690	35,957 Added 7.43%	519,775 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $692,350 - $915,000	-305,000 Reduced 38.67%	483,818 $1.17 Million
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $145,863 - $244,097	-59,536 Reduced 7.02%	788,818 $2.41 Million
Q2 2021 Aug 16, 2021	SELL	$3.0 - $4.39 $1.93 Million - $2.83 Million	-644,260 Reduced 43.16%	848,354 $3.3 Million
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $3.28 Million - $7.54 Million	1,492,614 New	1,492,614 $5.34 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.